Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male, under the age of 80; 2) Meet any of the following criteria: a) Digital rectal examination (DRE) revealed suspicious nodules in the prostate, with any PSA values; b) PSA=10 µ g/L; c) 4 µ g/L=PSA<10 µ g/L, f/t PSA=0.16; 3) Suspicious lesions were found through mp-MRI, at least one lesion with PI-RADS = 3; 4) Good compliance, able to communicate well with researchers; 5) Volunteer to participate in the research and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Confirmed prostate cancer or acute prostatitis patients; 2) During the acute infection period, or clinical significance urinary tract infections; 3) Prostate biopsy performed within one month; 4) In the period of decompensation due to cardiac insufficiency; 5) Individuals with severe bleeding tendencies, or those who are unable to stop taking anticoagulants for a long time; 6) Severe internal hemorrhoids, external hemorrhoids, perianal or rectal lesions; 7) Patients with severe bone and joint diseases who cannot undergo lithotomy; 8) Having a hypertensive crisis; 9) Individuals who are unable to undergo anesthesia; 10) Those who suffer from mental illness or mental disorders and are unable to understand the informed consent form; 11) People who use electronic instruments such as built-in pacemakers, cochlear implants, and nerve stimulators; 12) Other contraindications to surgery, or those deemed unsuitable by the researcher to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of cs-PCa; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of any-PCa; | — |
Countries
China
Contacts
Chinese PLA General Hospital